Gold Sponsors
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.Our medicines reach more than 250 million people worldwide.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries.
Silver Sponsor
Exhibitors
GULF DRUG:
Pharmaceuticals division stands as a cornerstone in the provision of comprehensive pharmaceuticals, over-the-counter and consumer health products sourced from world-class manufacturers and renowned brands. As a trusted pharmaceutical agent and distributor for leading multinational enterprises, we specialize in delivering innovative healthcare solutions in UAE.
With unwavering commitment to excellence, integrity, and strategic partnerships, we drive transformative access to life-saving medications and cutting-edge therapies.
Backed by a legacy of reliability and forward-thinking expertise, we are dedicated to shaping a healthier, more sustainable world for generations to come.
NEOVII:
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. Neovii’s global headquarters are located in Rapperswil, Switzerland, and its biologics manufacturing site and German operations are located in Gräfelfing, Germany. Neovii employs approximately 150 employees and has a presence in more than 40 countries worldwide and Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.
Pharmatrade, established in 1977, is a leading distribution company in the UAE supplying a comprehensive range of Medical and Pharmaceutical products from over 30 Multinational companies in the Healthcare field.
With over 5000 products in its portfolio the company has a significant share of the healthcare market covering both the Government and Private sectors.
The Distribution network covers Hospitals, Clinics, Laboratories, Diagnostic Centers and retail Pharmacies in all of the United Arab Emirates.
Internally the Company is organized along three Divisions: Pharmaceutical, Medical and Laboratory, each one representing a number of major players in their dedicated fields of specialty.
Headquartered in Dubai (UAE), the company has extensive offices and warehousing facilities in Dubai and Abu Dhabi. The Pharmatrade Group comprises five affiliated companies – Pharmatrade LLC, Symed LLC, Pharmaserve FZCO, Medysinal FZCO and Community Health Solutions LLC, all focused in different areas of the Healthcare sector.
At Sanofi, we chase the miracles of science to improve people’s lives. We are an innovative global healthcare company, driven by one purpose; to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life changing treatments and protection of life saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries. From our beginning as a local French enterprise to our position as a leading global healthcare company, reinvention is in our DNA and reflects our quest to make life better for patients, partners, communities, and our own people.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, we have a robust clinical pipeline of investigational small molecule, mRNA, cell and genetic therapies (including gene editing) in other serious diseases where we have deep insight into causal human biology, including sickle cell disease (SCD), beta thalassemia, acute and neuropathic pain, APOL1-mediated kidney disease (AMKD), type 1 diabetes and alpha1-antitrypsin deficiency (AATD).
Founded in 1989 in Cambridge, Mass., Vertex’s global headquarters is now located in Boston’s Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as oneofthe industry’s top places to work, including 13 consecutive years on Science magazine’s Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex’s history of innovation, visit www.vrtx.com or follow us on Twitter and LinkedIn.
